Kangmin Pharmaceutical (01681.HK) plans to implement a share repurchase plan.

The Zhixingtong Finance and Economics APP reported that Kangchen Pharmaceuticals (01681.HK) announced that the company has decided to authorize the Board of Directors to repurchase company shares through a general mandate at the annual general meeting of shareholders to be held on May 26, 2026. The company will repurchase shares in the public market, with a total fund of up to HK$200 million available for the proposed share repurchase.